Emergence of fluoroquinolone only-resistant Escherichia coli in a community hospital [4]

Clinical Infectious Diseases

Volumn 44, Issue 9, 2007, Pages 1255-

  Perla, Rocco J ^a,c   Knutson, Eric L ^a   Belliveau, Paul P ^b  

^a HealthAlliance Hospital   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; COMMUNITY HOSPITAL; ESCHERICHIA COLI; HUMAN; LETTER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; URINARY TRACT INFECTION; DRUG EFFECT; PHYSIOLOGY;

DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLUOROQUINOLONES; HOSPITALS, COMMUNITY; HUMANS;

EID: 34247197195     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513582     Document Type: Letter

References (3)

1. Karlowsky JA, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob Agents Chemother 2003; 47:1672-80.
2. Komp Lindgren P, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolone resistatance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 2003; 47:3222-32.
3. Zhanel GG, Karlowsky JA, Harding GKM, et al. A Canadian national survey of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. Antimicrob Agents Chemother 2000; 44:1089-92.